Anna Edmison

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Pfizer (United States)12.6%
• Bristol-Myers Squibb (United States)10.3%
• United States Food and Drug Administration9.1%
• Takeda (United States)9.1%
• GlaxoSmithKline (United States)7.1%
• AstraZeneca (United States)6.7%
• Other45.1%

Fields

• Immunology and Microbiology53.6%
• Medicine14.3%
• Biochemistry, Genetics and Molecular Biology10.7%
• Chemistry7.1%
• Pharmacology, Toxicology and Pharmaceutics7.1%
• Agricultural and Biological Sciences3.6%
• Other3.6%

Topics

• Biosimilars and Bioanalytical Methods25.8%
• Biosensors and Analytical Detection11.3%
• CAR-T cell therapy research9.7%
• Monoclonal and Polyclonal Antibodies Research8.1%
• Advanced Biosensing Techniques and Applications8.1%
• Innovative Microfluidic and Catalytic Techniques Innovation6.5%
• Other30.6%